MONTREAL--(Marketwire - Jan. 4, 2008) - Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, today announced the Canadian launch of SEASONALETM, the first and only extended-cycle oral contraceptive available in this country. With SEASONALETM, Canadian women now have a new contraceptive option that will allow them to have just four periods per year.
"We are very pleased to have strengthened our Women's health franchise with the addition of SEASONALETM. With approximately 3,600 physicians writing 50% of the prescriptions in Canada, SEASONALETM is a clear therapeutic fit for Paladin. As such, we are very excited to be bringing this exclusive product to Canadian women and believe that this next-generation oral contraceptive option will be the preferred choice of many," said Jonathan Ross Goodman, President and Chief Executive Officer of Paladin Labs Inc.
SEASONALETM, (levonorgestrel and ethinyl estradiol 0.15mg/0.03mg tablets), is a safe and effective contraceptive option for women, striking a balance between the benefits of having fewer periods with the reassurance of still having some periods. SEASONALETM will appeal most to busy women who do not want to deal with the inconveniences of a monthly period and to women who suffer from period-related symptoms such as cramping, heavy bleeding and headaches.
No comments:
Post a Comment